TP53 and cancer: We identified 28 reportable (pathogenic or likely pathogenic) mostly somatic splice-altering variants in a cohort of 247 patients with high-risk paediatric cancers [28], notably in the well-established cancer genes TP53, NF1, and RB1 (Fig. 5C–E).